Even daily injections of large amounts of IFN-α14 or IFN-α17 for the two first weeks of primary EBV infection in HIS mice only transiently suppress EBV viral loads and CD8+ T cell expansion [24]. Here, CD8A is linked to Epstein-Barr virus infection.